NovImmune Company
NovImmune is a Swiss pharmaceutical development company that specializes in discovering and developing therapeutic monoclonal antibodies to treat immune-related disorders. The company was founded in 1998 and is privately held.
Connections
Funding Status:
N/A
Headquarters:
Switzerland
Founded Date:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Technology:
COVID
Employee Number:
N/A
Number Of Exists:
N/A
Industry:
Treatments